Viral Hepatitis Grand Rounds - Home Page

ViralHep_GR_Perelman_www2012_v2.jpg  

Jointly provided by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.

 Perelman School of Medicine Small JPEG         VE logo 300px  

GrandRound_Live_Series_Schedule_button.jpg          

 

Series Overview:

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity "HIV Grand Rounds" which, in partnership with the Perelman School of Medicine at the University of Pennsylvania, is preparing for its eighth year running. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet on 2 Wednesdays each month at 12:00 pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.

Presentations cover the most important and current topics in hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.

Back to Top

Target Audience:

The program has been designed for physicians, fellows, residents, medical students, physician assistants, pharmacists, medical assistants, professional nurses, advanced pracice nurses in dermatology, family medicine, internal medicine, infectious diseases, obstetrics and gynecology, pediatrics, psychiatry and neurology.

Back to Top

Commercial Support Acknowledgement:

These activities are supported by educational grants from Gilead Sciences Medical Affairs and Merck & Co. Inc.

Back to Top

Learning Objectives for the Series:

Upon completion of the program, participants should be able to:
  • Demonstrate increased understanding of the epidemiology of and risk factors for viral hepatitis and NASH
  • Increase the rate of testing of viruses associated with hepatitis, such as NASH
  • Demonstrate improved knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral and non-viral hepatitis, including those with NASH  
  • Demonstrate an improved understanding of the treatment of hepatitis in patients co-infected with HIV or other viral infections

 

Course Directors:

K. Rajender Reddy MD

K. Rajender Reddy, MD

Ruimy Family President's Distinguished Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director, Viral Hepatitis Center
Medical Director, Liver Transplantation

University of Pennsylvania

Philadelphia, Pennsylvania

faculty photo
 

David E. Kaplan, MD, MSc

Associate Professor of Medicine
Division of Gastroenterology 
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

 

 Soccio, Raymond

Raymond Soccio, MD

Assistant Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

 

 
                       
 

 Back to Top

Back to Top

Live Session Topic and Speaker:

The next presentation of Hepatitis Grand Rounds from the
Perelman School of Medicine at the University of Pennsylvania:


Date: February 13, 2019

Speaker: David Kaplan, MD and Raymond Soccio, MD

Topic: Hepatitis Grand Rounds Preview/Cases


   Upcoming PROGRAM SCHEDULE   


 



 
 

    Hardware/Software Notice:

    You will need Internet to participate in this activity.

    Accreditation Statement:

     

               In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the                Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for                the healthcare team.

 

            Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the              credit commensurate with the extent of their participation in the activity.

            Nurses: This activity is not approved for nursing contact hours

             Pharmacists: This activity is not approved for pharmacy contact hours

            PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by             ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

 

               It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an             educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or             services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to                include financial relationships of a spouse or partner.

               The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on                valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty                presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In                addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

          The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE), Mila Kostic, CHCP, FACEHP, Director of CME and            Co-Director of IPCE Penn Medicine, Zalman Agus, MD, Senior Peer Reviewer and Patricia A. Smith, DNP, RN-BC, Penn IPCE Lead Nurse                     Planner have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational             activity.

    Back to Top

    following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

     Brian Boyle, MD
     Rick Gordon
     Oliver Fultz
     Mila Kostic, CHCP, FACEHP
           
     

     

    The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

    Presenters Name Commercial Supporter Relationship

    Planning Committee Members Disclosures:

    K. Rajender Reddy, MD

    Gilead; AbbVie; Merck

    Advisory Board

     

    Merck; AbbVie; Gilead; BMS; Janssen

    Research Grants

    David Kaplan, MD

    Bayer Pharmaceuticals; Invio Pharmaceuticals

    Investigator

     

    Gilead

    Research Grants

    Ian Frank, MD

    Gilead

    Advisory Board

     

    ViiV; GSK

    Research Grants

    Back to Top

    Discussion of Investigational and/or Off-label Use of Commercial Products and Devices:

    The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

    Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

    Back to Top

    Disclaimer:

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

    Back to Top

     GrandRound_Live_Series_Schedule_button.jpg          

    You may contact Richard Gordon by phone at 1-773-368-3932 or by email at Rgordon@viraled.com for additional assistance.

    For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME: penncme@mail.med.upenn.edu.

    We look forward to bringing the highest quality, outcomes driven CME directly to you.

    Perelman School of Medicine Small JPEG                                                                    VE logo 300px

Prepare to print

Share this page:

Get link code to this page     


Back to Top